Fennec Pharmaceuticals (FENC) Superinvestor holders
8 of the superinvestors we track hold Fennec Pharmaceuticals (FENC) in their latest 13F filings, $7M in total.
Summary
The largest holder is Paul Marshall (Marshall Wace), with $1M, 0.0% of the portfolio.
In their latest quarter: 6 opened a new position, 1 added.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Paul Marshall Marshall Wace |
New position | 138,758 | $1M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
New position | 134,200 | $1M | 0.0% | Q2 2026 |
| Didric Cederholm Lion Point Capital |
Held | 112,434 | $1M | 5.8% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 92,889 | $998,557 | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
New position | 60,332 | $648,569 | 0.0% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
New position | 56,407 | $606,375 | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
New position | 21,474 | $230,846 | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
New position | 8,882 | $94,000 | 0.0% | Q3 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 7 |
| Q1 2026 | 3 |
| Q4 2025 | 8 |
| Q3 2025 | 6 |
| Q2 2025 | 4 |
| Q1 2025 | 3 |
| Q4 2024 | 2 |
| Q3 2024 | 2 |
Questions about Fennec Pharmaceuticals
Which superinvestors own Fennec Pharmaceuticals?
8 of the superinvestors we track hold Fennec Pharmaceuticals (FENC) in their latest 13F filings, $7M in total. Paul Marshall, Jim Simons, Didric Cederholm, Cliff Asness, Two Sigma, Steve Cohen.
Who is the largest superinvestor holder of FENC?
The largest holder is Paul Marshall (Marshall Wace), with $1M, 0.0% of the portfolio.
From Fennec Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.